vs
德康医疗（DXCM）与PROG Holdings, Inc.（PRG）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是PROG Holdings, Inc.的1.9倍（$1.3B vs $651.6M），德康医疗净利率更高（21.2% vs 5.5%，领先15.7%），PROG Holdings, Inc.同比增速更快（457.1% vs 21.6%），过去两年德康医疗的营收复合增速更高（12.0% vs 4.9%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
PROG Holdings是一家总部位于美国的金融科技企业，主要面向美国本土市场提供灵活的租购及销售点融资解决方案，核心业务涵盖零售合作伙伴融资、消费信贷与支付服务，帮助消费者无需满足传统信用要求即可购买电子产品、家居用品等商品。
DXCM vs PRG — 直观对比
营收规模更大
DXCM
是对方的1.9倍
$651.6M
营收增速更快
PRG
高出435.5%
21.6%
净利率更高
DXCM
高出15.7%
5.5%
两年增速更快
DXCM
近两年复合增速
4.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $651.6M |
| 净利润 | $267.3M | $36.1M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 25.6% | 10.0% |
| 净利率 | 21.2% | 5.5% |
| 营收同比 | 21.6% | 457.1% |
| 净利润同比 | 153.6% | 3.8% |
| 每股收益（稀释后） | $0.67 | $3.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMPRG
| Q1 26 | $1.3B | $651.6M | ||
| Q4 25 | $1.3B | $525.4M | ||
| Q3 25 | $1.2B | $595.1M | ||
| Q2 25 | $1.2B | $604.7M | ||
| Q1 25 | $1.0B | $684.1M | ||
| Q4 24 | $1.1B | $558.9M | ||
| Q3 24 | $994.2M | $606.1M | ||
| Q2 24 | $1.0B | $592.2M |
净利润DXCMPRG
| Q1 26 | $267.3M | $36.1M | ||
| Q4 25 | $267.3M | $40.5M | ||
| Q3 25 | $283.8M | $33.1M | ||
| Q2 25 | $179.8M | $38.5M | ||
| Q1 25 | $105.4M | $34.7M | ||
| Q4 24 | $151.7M | $57.5M | ||
| Q3 24 | $134.6M | $84.0M | ||
| Q2 24 | $143.5M | $33.8M |
毛利率DXCMPRG
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
营业利润率DXCMPRG
| Q1 26 | 25.6% | 10.0% | ||
| Q4 25 | 25.6% | 6.9% | ||
| Q3 25 | 20.1% | 9.0% | ||
| Q2 25 | 18.4% | 10.0% | ||
| Q1 25 | 12.9% | 8.2% | ||
| Q4 24 | 17.0% | 8.9% | ||
| Q3 24 | 15.3% | 8.1% | ||
| Q2 24 | 15.7% | 9.4% |
净利率DXCMPRG
| Q1 26 | 21.2% | 5.5% | ||
| Q4 25 | 21.2% | 7.7% | ||
| Q3 25 | 23.5% | 5.6% | ||
| Q2 25 | 15.5% | 6.4% | ||
| Q1 25 | 10.2% | 5.1% | ||
| Q4 24 | 13.6% | 10.3% | ||
| Q3 24 | 13.5% | 13.9% | ||
| Q2 24 | 14.3% | 5.7% |
每股收益（稀释后）DXCMPRG
| Q1 26 | $0.67 | $3.68 | ||
| Q4 25 | $0.67 | $0.99 | ||
| Q3 25 | $0.70 | $0.82 | ||
| Q2 25 | $0.45 | $0.95 | ||
| Q1 25 | $0.27 | $0.83 | ||
| Q4 24 | $0.37 | $1.33 | ||
| Q3 24 | $0.34 | $1.94 | ||
| Q2 24 | $0.35 | $0.77 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $69.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $774.4M |
| 总资产 | $6.3B | $2.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMPRG
| Q1 26 | $917.7M | $69.4M | ||
| Q4 25 | $917.7M | $308.8M | ||
| Q3 25 | $1.8B | $292.6M | ||
| Q2 25 | $1.2B | $222.0M | ||
| Q1 25 | $904.9M | $213.3M | ||
| Q4 24 | $606.1M | $90.9M | ||
| Q3 24 | $621.2M | $221.7M | ||
| Q2 24 | $939.2M | $250.1M |
总债务DXCMPRG
| Q1 26 | — | — | ||
| Q4 25 | — | $594.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $643.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益DXCMPRG
| Q1 26 | $2.7B | $774.4M | ||
| Q4 25 | $2.7B | $746.4M | ||
| Q3 25 | $2.7B | $703.6M | ||
| Q2 25 | $2.6B | $668.7M | ||
| Q1 25 | $2.3B | $654.4M | ||
| Q4 24 | $2.1B | $650.3M | ||
| Q3 24 | $2.0B | $630.8M | ||
| Q2 24 | $2.4B | $581.9M |
总资产DXCMPRG
| Q1 26 | $6.3B | $2.0B | ||
| Q4 25 | $6.3B | $1.6B | ||
| Q3 25 | $7.5B | $1.5B | ||
| Q2 25 | $7.3B | $1.5B | ||
| Q1 25 | $6.8B | $1.5B | ||
| Q4 24 | $6.5B | $1.5B | ||
| Q3 24 | $6.4B | $1.4B | ||
| Q2 24 | $6.8B | $1.5B |
负债/权益比DXCMPRG
| Q1 26 | — | — | ||
| Q4 25 | — | 0.80× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.99× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
